Related Experiment Video
Updated: Mar 29, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and
Lindsey E Romick-Rosendale1, Elizabeth E Hoskins1, Lisa M Privette Vinnedge1
1Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Purpose:
Head and neck squamous cell carcinoma (HNSCC) remains a devastating disease, and Fanconi anemia (FA) gene mutations and transcriptional repression are common. Invasive tumor behavior is associated with poor outcome, but relevant pathways triggering invasion are poorly understood. There is a significant need to improve our understanding of genetic pathways and molecular mechanisms driving advanced tumor phenotypes, to develop tailored therapies. Here we sought to investigate the phenotypic and molecular consequences of FA pathway loss in HNSCC cells.
Experimental Design:
Using sporadic HNSCC cell lines with and without FA gene knockdown, we sought to characterize the phenotypic and molecular consequences of FA deficiency. FA pathway inactivation was confirmed by the detection of classic hallmarks of FA following exposure to DNA cross-linkers. Cells were subjected to RNA sequencing with qRT-PCR validation, followed by cellular adhesion and invasion assays in the presence and absence of DNA-dependent protein kinase (DNA-PK) and Rac1 inhibitors.
Results:
We demonstrate that FA loss in HNSCC cells leads to cytoskeletal reorganization and invasive tumor cell behavior in the absence of proliferative gains. We further demonstrate that cellular invasion following FA loss is mediated, at least in part, through NHEJ-associated DNA-PK and downstream Rac1 GTPase activity.
Conclusions:
These findings demonstrate that FA loss stimulates HNSCC cell motility and invasion, and implicate a targetable DNA-PK/Rac1 signaling axis in advanced tumor phenotypes.
Insights
Loss of Fanconi anemia (FA) pathway genes in head and neck squamous cell carcinoma (HNSCC) promotes cell invasion. This invasive behavior is driven by DNA-PK and Rac1 signaling, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Head and neck squamous cell carcinoma (HNSCC) is a significant cause of cancer mortality.
- Invasive tumor behavior in HNSCC correlates with poor patient outcomes.
- The molecular pathways driving HNSCC invasion are not fully understood.
Purpose of the Study:
- To investigate the phenotypic and molecular effects of Fanconi anemia (FA) pathway loss in HNSCC.
- To identify genetic pathways and molecular mechanisms underlying advanced HNSCC phenotypes.
Main Methods:
- Utilized HNSCC cell lines with and without FA gene knockdown.
- Confirmed FA pathway inactivation via DNA cross-linker sensitivity.
- Performed RNA sequencing, qRT-PCR, and invasion assays with specific inhibitors (DNA-PK, Rac1).
Main Results:
- FA loss induced cytoskeletal changes and increased HNSCC cell invasion without affecting proliferation.
- Cellular invasion due to FA loss was partly mediated by DNA-PK and Rac1 activity.
- Identified a link between FA pathway deficiency and enhanced tumor cell motility.
Conclusions:
- Fanconi anemia pathway loss significantly enhances HNSCC cell motility and invasion.
- A targetable DNA-PK/Rac1 signaling axis is implicated in FA-deficient HNSCC.
- These findings suggest potential therapeutic strategies for advanced HNSCC.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression

